EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr | ₹264 Cr |
What is the latest Net Cash Inflow / Outflow ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-56 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹-172 Cr |
| Mar2021 | ₹264 Cr |
How is Net Cash Inflow / Outflow of EMCURE PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-56 Cr | Negative | |
| Mar2024 | ₹221 Cr | 64.85 | |
| Mar2023 | ₹134 Cr | Positive | |
| Mar2022 | ₹-172 Cr | Negative | |
| Mar2021 | ₹264 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹26,824.6 Cr | -2.7% | -7.8% | 45.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.7% |
-7.8% |
45.8% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses